Jedidiah Grisel, MD
Otolaryngology · Wichita Falls, TXNPI 1285845586
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,258 of the $3,551 with a category attached, or 63.6%. 25 manufacturers reported payments, led by Cochlear Americas at 43.1% of the total. Reporting peaked in 2019 at $1,615 and has fallen 54.9% since, to $729 in 2025.
Across 82 payments — averaging $43.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cochlear Americas$2K
- Regeneron Healthcare Solutions, Inc.$314
- Stryker$277
- Medtronic$250
- Integra Lifesciences Corporation$196
- Sanofi$191
- plus $792 from 19 others
Across 10 payments — averaging $2502.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cochlear Americas$25K
What the payments were for
- Consulting fees$90025%
- Travel & lodging$34010%
- Food & beverage$2,25864%
- Education$531%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cochlear Americas | 10 | $1,531 |
| Regeneron Healthcare Solutions, Inc. | 14 | $314 |
| Stryker | 9 | $277 |
| Medtronic | 6 | $250 |
| Integra Lifesciences Corporation | 2 | $196 |
| Sanofi | 7 | $191 |
| GSK | 6 | $125 |
| Inspire Medical Systems, Inc. | 2 | $81 |
| Optinose US, Inc. | 4 | $77 |
| Acclarent, Inc | 2 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Neurent Medical Limited | 3 | $57 |
| Smith+Nephew | 2 | $50 |
| Johnson & Johnson | 1 | $37 |
| Blueprint Medicines Corporation | 1 | $31 |
| Iotamotion, Inc. | 1 | $26 |
| Intersect ENT, Inc. | 1 | $26 |
| Olympus America Inc. | 1 | $24 |
| Novartis | 1 | $23 |
| Advanced Bionics, LLC | 1 | $22 |
| Aerin Medical Inc. | 1 | $20 |
| Kaleo, Inc. | 1 | $19 |
| Cook Medical LLC | 1 | $17 |
| Cycle Pharmaceuticals Inc | 1 | $16 |
| IBSA Pharma Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nucleus$1,365
- Baha$1,365
- Acclarent Aera$174
- Inspira Air$174
- RELIEVA SPINPLUS NAV$174
- TruDi Probe$174
- PROPEL$126
- ENTELLUS - XPRESS ENT DILATION SYSTEM$101
- CLARIFIX$100
How this compares
$3,551 in reported general payments places this provider in the 65th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 12 | $44,087 |
| Ipratropium Bromide | 107 | $4,169 |
| Epinephrine | 13 | $1,419 |
| Fluticasone Propionate | 46 | $1,112 |
| Azelastine Hcl | 24 | $1,096 |
| Levothyroxine Sodium | 34 | $433 |
| Ciprofloxacin Hcl | 33 | $376 |
| Amitriptyline Hcl | 32 | $347 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 29 | $317 |
| Methylprednisolone | 39 | $297 |
| Doxycycline Hyclate | 15 | $175 |
| Tramadol Hcl | 62 | $175 |
| Famotidine | 11 | $116 |
| Mupirocin | 14 | $98 |
| Cephalexin | 24 | $68 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Wichita Falls
- Marc DeanFort Worth$486K
- Amber LuongHouston$426K
- Arjuna KuperanHouston$348K
- Ronald KuppersmithCollege Station$325K
- Ron KarniHouston$317K
- Philip ChenSan Antonio$305K
- Jordan RihaniSouthlake$280K
- Keith MathenyFrisco$269K
- Martin CitardiHouston$245K
- James AtkinsSan Antonio$205K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.